Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gut-Brain Axis01:22

Gut-Brain Axis

195
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
195
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

2.5K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.5K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

1.2K
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
1.2K
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

19
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility...
19
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

1.4K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.4K
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

956
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
956

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High prevalence of CNS-directed autoantibodies in patients with schizophrenia.

bioRxiv : the preprint server for biology·2026
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Brexpiprazole for the Treatment of Co-occurring Schizophrenia and Substance Use Disorder: A Multisite, Randomized, Controlled Trial.

The Journal of clinical psychiatry·2025
Same author

Reliability of remote self-administered digital cognitive assessments: preliminary validation study.

Frontiers in digital health·2025
Same author

White matter hyperintensities, inflammation and cognitive impairments in drug-naïve first episode schizophrenia patients: a cross-sectional study.

BMC psychiatry·2025
Same author

Performance of a Digital Cognitive Assessment in Predicting Dementia Stages Delineated by the Dementia Severity Rating Scale: Retrospective Study.

JMIR aging·2025

Related Experiment Video

Updated: Apr 23, 2026

A Gut-on-a-Chip Model to Study the Gut Microbiome-Nervous System Axis
09:18

A Gut-on-a-Chip Model to Study the Gut Microbiome-Nervous System Axis

Published on: July 28, 2023

4.3K

Schizophrenia and the gut-brain axis.

Katlyn Nemani1, Reza Hosseini Ghomi2, Beth McCormick3

  • 1NYU School of Medicine, New York, NY, United States.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|September 22, 2014
PubMed
Summary

Schizophrenia risk factors may stem from gut health issues, including inflammation and barrier dysfunction. Dietary changes and gut microbiota modulation show promise for managing symptoms and improving patient outcomes.

Keywords:
GlutenGutInflammationMicrobiotaProbioticsSchizophrenia

More Related Videos

Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells
08:04

Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells

Published on: November 19, 2020

6.1K
Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
07:49

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice

Published on: June 2, 2022

2.9K

Related Experiment Videos

Last Updated: Apr 23, 2026

A Gut-on-a-Chip Model to Study the Gut Microbiome-Nervous System Axis
09:18

A Gut-on-a-Chip Model to Study the Gut Microbiome-Nervous System Axis

Published on: July 28, 2023

4.3K
Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells
08:04

Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells

Published on: November 19, 2020

6.1K
Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
07:49

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice

Published on: June 2, 2022

2.9K

Area of Science:

  • Neurogastroenterology
  • Immunopsychiatry
  • Microbiome research

Background:

  • Emerging evidence highlights the brain-gut axis, involving neural, hormonal, and immune pathways.
  • Schizophrenia is associated with increased gastrointestinal (GI) barrier dysfunction, food sensitivities, inflammation, and metabolic syndrome.
  • Gut microbiota composition may play a significant role in these observed pathologies.

Purpose of the Study:

  • To explore the link between gut health and schizophrenia risk factors.
  • To investigate the potential of dietary interventions and microbiota modulation in schizophrenia management.

Main Methods:

  • Review of existing literature on the gut-brain axis in schizophrenia.
  • Analysis of associations between GI issues, inflammation, metabolic syndrome, and schizophrenia.
  • Evaluation of therapeutic potential of gluten-free/casein-free diets, antimicrobials, and probiotics.

Main Results:

  • Common pathways in the intestinal tract link several schizophrenia risk factors.
  • Gastrointestinal barrier dysfunction, food antigen sensitivity, inflammation, and metabolic syndrome are prevalent in schizophrenia patients.
  • Gut microbiota composition is a potential influencing factor.

Conclusions:

  • A subgroup of schizophrenia patients may benefit from a gluten and casein-free diet.
  • Antimicrobials and probiotics demonstrate therapeutic potential for metabolic and immune dysregulation in schizophrenia.
  • Targeting the gut microbiome offers a promising avenue for schizophrenia treatment.